Following a presidential pardon earlier this year, Arthur Hayes, a Bitcoin investor and co-creator of the BitMEX exchange, has become a significant investor and board member in a regenerative medicine firm. The pardon, granted by former US President Donald Trump in March, absolved Hayes of his conviction related to violations of the Bank Secrecy Act.
Hayes, who propelled BitMEX to prominence as a leading cryptocurrency derivatives platform before encountering regulatory challenges, has been receiving treatments at the stem cell company’s facilities in both Mexico and Bangkok for over a year, according to a recent interview with Bloomberg.
“My goal is to extend my lifespan as much as possible, while maintaining optimal health,” Hayes stated, adding that numerous nations are easing restrictions regarding the use of stem cells. The company, currently undergoing a rebranding process, has not been publicly named.
In March, Trump issued pardons to four ex-BitMEX executives, including Hayes, Benjamin Delo, Gregory Dwyer, and Samuel Reed. They had previously pleaded guilty to Bank Secrecy Act violations, stemming from alleged inadequacies in Anti-Money Laundering protocols at the exchange.
Arthur Hayes
Related:
Utility, volatility and longevity: Looking beyond the hype
Crypto Leaders Invest in Longevity Research
Hayes’ investment in longevity solutions mirrors a broader trend among crypto entrepreneurs allocating resources to this emerging field.
In 2021, Vitalik Buterin donated $25 million in Shiba Inu (SHIB) tokens to the Future of Life Institute and more than $350,000 to the SENS Research Foundation, emphasizing a focus on “reimagining aging.”
He has previously described life extension as a worthy cause, seeing it as a way of tackling generational loss caused by aging. “Just even the process of aging turning into something that just becomes reversible and it being a regular thing for people to live one and a half, two centuries and then go even further from there,” Buterin mentioned.
Former Coinbase executive Balaji Srinivasan is a co-founder of Counsyl, a genomics company providing affordable genetic testing focused on reproductive health and screening for diseases. Brian Armstrong, CEO of Coinbase, established NewLimit, a genetic startup, which garnered $130 million in funding this year.
Cointelegraph has sought comments from Hayes, but a response has not yet been received as of this writing.
Related:
Experts to gather in Miami to drive longevity research forward
Hayes Stays Engaged in Crypto Sphere
Hayes has maintained a prominent presence within the digital currency world. His family office, Maelstrom, is supporting companies involved in managing digital asset treasuries, encompassing publicly listed entities investing in cryptocurrencies.
Earlier this year, Hayes’ Maelstrom fund introduced a Bitcoin grant program, offering annual grants from $50,000 to $150,000, with developers able to secure up to $250,000. This initiative promotes open-source innovation that aims to enhance the scalability, robustness, security, and resistance to censorship of the Bitcoin network.
Magazine:
AI will help us become ‘biologically immortal’ from 2030